MAPK8 and hepatocellular carcinoma: In HCC, it has been reported that JNK acts as both a tumor promoter, driving inflammation, fibrosis, and metabolic dysregulation, and a tumor suppressor, facilitating apoptosis and cell cycle arrest in damaged hepatocytes.